MedTrace Logo

Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)

NCT03929731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2025-11-18

No results posted yet for this study

Summary

To determine long-term outcomes, recurrence rates, and treatment needs in Polypoidal Choroidal Vasculopathy (PCV). Specifically, to describe the long-term outcomes, recurrence rates and treatment patterns PCV patients 5 years after first presentation. This study will also evaluate whether polyp closure within the first 12 months of therapy is associated with better long-term visual outcome and will also determine the risk of disease development in the fellow eye

Conditions

  • Polypoidal Choroidal Vasculopathy

Interventions

DIAGNOSTIC_TEST

Indocyanine Green Angiography

Intravenous injection of dye-indocyanine green

Sponsors & Collaborators

  • Singapore National Eye Centre

    lead OTHER_GOV

Principal Investigators

  • Principal Investigator · Singapore National Eye Centre

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-05
Primary Completion
2024-05-09
Completion
2024-05-09

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03929731 on ClinicalTrials.gov